synergy nash tirzepatide Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatide in nash Exploring the

The impact appears to be influenced by factors such as: Individual hormone sensitivity Starting weight and overall health status Duration of medication use Dosage levels Medical professionals emphasize that while these changes can occur, they're often temporary and may resolve as the body adjusts to the medication

Two notable compounds stand out: Teduglutide (brand name Gattex): FDA-approved for short bowel syndrome, used off-label for gut healing and digestive optimization

doi:10.3390/molecules25010182

Analysis of publication bias indicated a symmetrical distribution in the funnel plot, suggesting the absence of publication bias